Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM1A | O60341 | 2/20 | 0.32 |
| ▸ | KDM1B | Q8NB78 | 1/20 | 0.32 |
| ▸ | WNT3A | P56704 | 1/20 | 0.31 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.31 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL33526079 | 0.73 | IL1RN (0.33) | KDM1AKDM1BWNT3ATNKS2GRM2 | |
| SCHEMBL25819642 | 0.73 | KDM1A (0.33) | KDM1AKDM1B | |
| SCHEMBL2149123 | 0.73 | HTR2A (0.33) | WNT3ATNKS2GRM2 | |
| SCHEMBL18314277 | 0.71 | HTR2A (0.37) | — | |
| SCHEMBL33526483 | 0.66 | MAOA (0.38) | — | |
| SCHEMBL29336227 | 0.66 | ALDH1A1 (0.31) | — | |
| SCHEMBL31039569 | 0.64 | IL1RN (0.37) | WNT3ATNKS2 | |
| SCHEMBL21954990 | 0.64 | IL1RN (0.37) | WNT3ATNKS2 | |
| SCHEMBL24328553 | 0.63 | HTR2A (0.37) | KDM1AKDM1B | |
| SCHEMBL29661388 | 0.63 | HTR2A (0.37) | KDM1AKDM1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260091048-A1 | GIP RECEPTOR AGONIST COMPOUNDS | LILLY CO ELI (US) | 2026-04-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260091048-A1 | GIP RECEPTOR AGONIST COMPOUNDS | GIPR, GLP1R, GPR119 | KDM1A 3903/4885KDM1B 3626/4885WNT3A 1392/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.